Nevada Board of Pharmacy agenda packet references proposed NAC 453 Schedule I additions of two nitazene analogs

A Nevada State Board of Pharmacy meeting agenda packet (workshop item) references proposed amendments to Nevada’s controlled substances scheduling rules (NAC 453) to add two nitazene analogs—N-pyrrolidino metonitazene and N-pyrrolidino protonitazene—to Schedule I. The materials indicate the item is under consideration/proposed (not confirmed as adopted within the provided text). Compliance teams should monitor for subsequent adoption notices/amendments if finalized, as Schedule I placement would significantly restrict lawful handling and require registrant controls consistent with Schedule I substances.